Stock IVRN INNOVEREN SCIENTIFIC INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Innoveren Scientific Inc.

Equities

IVRN

US4041243076

Market Closed - OTC Markets
Other stock markets
 14:57:09 2024-06-03 EDT 		5-day change 1st Jan Change
0.0036 USD -34.55% Intraday chart for Innoveren Scientific Inc. 0.00% -96.90%
06-04 Innoveren Scientific Inc. announced that it has received $0.25 million in funding CI
03-06 Innoveren Scientific Announces 510(K) Submission to U.S. Federal Food and Drug Administration for Skindisc(Tm) Lite CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
H-CYTE, Inc. Appoints Richard Rosenblum and Matthew Anderer as Directors
CI
H-CYTE, Inc. Announces Resignation of Tanya Rhodes as Interim Chief Executive Officer
CI
H-CYTE, Inc. Appoints Michael Yurkowsky as Chief Executive Officer
CI
H-CYTE, Inc. Announces Executive Changes
CI
H-CYTE, Inc. Announces Designated of Tanya Rhodes from Technology Officer to Executive Officer
CI
H-Cyte, Inc. Announces Board Changes
CI
H-CYTE, Inc. Announces Executive Changes
CI
H CYTE : Robert Greif named Chief Executive Officer of H-CYTE
AQ
Robert Greif named Chief Executive Officer of H-CYTE
GL
H-CYTE, Inc. Announces Executive Changes
CI
H-Cyte, Inc. Announces Resignation of William Horne Company’s CEO and Chairman
CI
H-CYTE, Inc. Announces Executive Resignations
CI
H-CYTE, Inc. Announces Board Changes
CI
H-CYTE, Inc Appoints Atta Behfar to Its Board of Directors
CI
H-CYTE Inc. Appoints Andre Terzic to Board of Directors
CI
Medovex Corp. will Change its Name to H-CYTE, Inc
CI
MEDOVEX CORP will Change its Name to H-CYTE, Inc
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IVRN Stock
  4. News Innoveren Scientific Inc.
  5. Insiders